Your browser doesn't support javascript.
loading
Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial.
Harrison, Stephen A; Abdelmalek, Manal F; Neff, Guy; Gunn, Nadege; Guy, Cynthia D; Alkhouri, Naim; Bashir, Mustafa R; Freilich, Bradley; Kohli, Anita; Khazanchi, Arun; Sheikh, Muhammad Y; Leibowitz, Mark; Rinella, Mary E; Siddiqui, Mohammad S; Kipnes, Mark; Moussa, Sam E; Younes, Ziad H; Bansal, Meena; Baum, Seth J; Borg, Brian; Ruane, Peter J; Thuluvath, Paul J; Gottwald, Mildred; Khan, Mujib; Chen, Charles; Melchor-Khan, Liza; Chang, William; DePaoli, Alex M; Ling, Lei; Lieu, Hsiao D.
Afiliación
  • Harrison SA; Radcliffe Department of Medicine, University of Oxford, Oxford, UK; Pinnacle Clinical Research, San Antonio, TX, USA.
  • Abdelmalek MF; Division of Gastroenterology and Hepatology, Duke University, Durham, NC, USA.
  • Neff G; Covenant Research, Sarasota, FL, USA.
  • Gunn N; Pinnacle Clinical Research, San Antonio, TX, USA.
  • Guy CD; Department of Pathology, Duke University, Durham, NC, USA.
  • Alkhouri N; Arizona Liver Health, Tucson, AZ, USA.
  • Bashir MR; Department of Radiology and Medicine, Duke University, Durham, NC, USA.
  • Freilich B; Kansas City Research Institute, Kansas City, MO, USA.
  • Kohli A; Arizona Liver Health, Chandler, AZ, USA.
  • Khazanchi A; Florida Research Institute, Lakewood Ranch, FL, USA.
  • Sheikh MY; Fresno Clinical Research Center, Fresno, CA, USA.
  • Leibowitz M; National Research Institute, Los Angeles, CA, USA.
  • Rinella ME; Department of Medicine (Gastroenterology and Hepatology), Northwestern University, Chicago, IL, USA.
  • Siddiqui MS; Virginia Commonwealth University, Richmond, VA, USA.
  • Kipnes M; Diabetes & Glandular Disease Clinic, San Antonio, TX, USA.
  • Moussa SE; Adobe Clinical Research, Tucson, AZ, USA.
  • Younes ZH; Gastro One, Germantown, TN, USA.
  • Bansal M; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Baum SJ; Excel Medical Clinical Trials, Boca Raton, FL, USA.
  • Borg B; Southern Therapy and Advanced Research, Jackson, MS, USA.
  • Ruane PJ; Ruane Clinical Research, Los Angeles, CA, USA.
  • Thuluvath PJ; Mercy Medical Center, Baltimore, MD, USA.
  • Gottwald M; NGM Biopharmaceuticals, South San Francisco, CA, USA.
  • Khan M; NGM Biopharmaceuticals, South San Francisco, CA, USA.
  • Chen C; NGM Biopharmaceuticals, South San Francisco, CA, USA.
  • Melchor-Khan L; NGM Biopharmaceuticals, South San Francisco, CA, USA.
  • Chang W; NGM Biopharmaceuticals, South San Francisco, CA, USA.
  • DePaoli AM; NGM Biopharmaceuticals, South San Francisco, CA, USA.
  • Ling L; NGM Biopharmaceuticals, South San Francisco, CA, USA. Electronic address: lling@ngmbio.com.
  • Lieu HD; NGM Biopharmaceuticals, South San Francisco, CA, USA.
Lancet Gastroenterol Hepatol ; 7(7): 603-616, 2022 07.
Article en En | MEDLINE | ID: mdl-35325622
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Factores de Crecimiento de Fibroblastos / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Lancet Gastroenterol Hepatol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Factores de Crecimiento de Fibroblastos / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Lancet Gastroenterol Hepatol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos